Long-term data show watch-and-wait is viable for rectal cancer, with most regrowths salvageable despite adverse baseline MRI features. Long-term data presented at the ESMO GI 2026 Congress provide new ...

BC, OCN, ONN-CG, an oncology nurse navigator and clinical advocate at Hackensack Meridian Ocean University Medical Center, ...

Hughes discusses managing GI toxicities and the need for research regarding GLP-1 use among breast cancer patients and ...

Oncology nurse Kerry Mann details the protocols and patient-centered strategies for bringing advanced precision medicine to local community clinics. The landscape of cancer care is shifting as ...

The FDA approved palbociclib (Ibrance) for maintenance in HR+/HER2+ metastatic breast cancer after induction therapy, based ...

Pamela Plasket, RN, discusses the evolving role of oncology nurses as lung cancer patients survive longer on advanced therapies like BiTEs. The landscape of thoracic oncology is undergoing a ...

The FDA approved Tregzi, a precision-engineered cell therapy, to improve chronic GVHD-free survival in adults undergoing allogeneic transplant. The U.S. Food and Drug Administration (FDA) has approved ...

The FDA approved Azurity’s Aprepitant Injectable Emulsion, a polysorbate-80-free, ready-to-use IV option for preventing chemotherapy-induced nausea. The U.S. Food and Drug Administration (FDA) has ...

Oncology nurse Diane Stanaway offers essential sun protection strategies as NJ prepares for the heat of the 2026 World Cup and rising skin cancer rates. As MetLife Stadium in East Rutherford, New ...

The FDA approved the BESREMi Pen for polycythemia vera, offering a simplified self-administration option to improve patient adherence and care. PharmaEssentia USA Corporation has announced that the ...

The core of this optimization strategy is the geriatric assessment. At Mount Sinai, Jakubowski noted that patients aged 65 and older — and in some cases, those 60 and older — receive a comprehensive ...